Clinical Trial Update: Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled cannabis (vaped marijuana) to attenuate naloxone-precipitated withdrawal in the context of opioid overdose; the study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose
• Opioid Use Disorder

Drugs mentioned

• Vaped marijuana (cannabis inhalation product)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid Overdose | Phase 2 | Status: TERMINATED | Results posted: 2025-03-18